The gut microbiome has clear implications for health and disease. Recent evidence of this comes from a US FDA vote for approval of the microbiome-based drug RBX2660, created by Rebiotix Inc, A Ferring Company, to treat potentially deadly bacterial infections with Clostridium difficile (Cdiff). Cdiff is a common gut bacteria that may cause severe diarrhea...
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease targeting the central nervous system with a prevalence of around 2.8 million people globally. The etiopathogenesis of MS is multifactorial and involves environmental factors. Amongst the environmental factors, the gut microbiota is a key player modulating MS. Dietary habits drive the gut microbiome. Thus, dietary shifts change...
We are pleased to announce the 2022 CosmosID North & South America Grant Program Winners! We are awarding a group of three scientists with funding and resources along their journey in the microbiome space. The winners are each receiving 90 samples extracted and sequenced, taxonomic profiling, functional profiling, statistical comparative analysis & a CosmosID-HUB bronze subscription! Each...
Congratulations to our three 2022 Grant Program for Scientists & Start-Ups North and South America winners! We are awarding a group of scientists with funding and resources along their journey in the microbiome space. The winners are receiving 90 samples extracted and sequenced, taxonomic profiling, functional profiling, statistical comparative analysis & a CosmosID-HUB bronze subscription! The...
Congratulations to our three 2022 Grant Program for Scientists & Start-Ups North and South America winners! We are awarding a group of scientists with funding and resources along their journey in the microbiome space. The winners are receiving 90 samples extracted and sequenced, taxonomic profiling, functional profiling, statistical comparative analysis & The Metagenomics App bronze...
Congratulations to our three 2022 Grant Program for Scientists & Start-Ups North and South America winners! We are awarding a group of scientists with funding and resources along their journey in the microbiome space. The winners are receiving 90 samples extracted and sequenced, taxonomic profiling, functional profiling, statistical comparative analysis & a CosmosID-HUB bronze subscription! The...
A recent article featured on BBC highlights that the gut microbiome may have a greater role in the improvement of health through exercise than we previously thought. Our guts are alive with a vast diversity of microbial residents. Their roles range from fermenting dietary fibers, vitamin synthesis, and fat metabolism regulation to immune support against...
Nasal swabs and saliva are conventional methods for detection of SARS-CoV-2, but the virus is also present in feces. Therefore, fecal material in wastewater samples could be used to track community dynamics of the virus. To do that, Brumfield et al. (2022) collected wastewater samples from manholes and then processed them for microbial genome sequencing...
Diet drinks that contain non-nutritive sweeteners (NNS) have been around for more than 60 years. Since the dawn of the diet drink introduction to the market, a fizzing debate began; do the sweeteners, including aspartame, saccharine, sucralose and stevia, do more harm than good? Are they just innocent satisfiers of our urge to consume sweets...
Over the last decade, the field of metagenomics has grown extensively, leading to an exponential increase in sequencing data in public data repositories. Availability of this huge collection of data has accelerated the discovery of novel microbiome-related biomarkers and microbiome-based novel biomedical therapeutics. One of the key steps in identifying potential biomarkers or lead candidates...
© 2023 CosmosID. All rights reserved